The Levels of Somatostatin Receptors in Causative Tumors of Oncogenic Osteomalacia Are Insufficient for Their Agonist to Normalize Serum Phosphate Levels

Revised Equations for Estimated GFR From Serum Creatinine in Japan

Seiichi Matsuo, Enyu Imai, Masaru Horio et al. · American Journal of Kidney Diseases · 2009 · 6.4K citations

Pharmacy, Nephrology, Renal Pharmacokinetics +9

The parathyroid is a target organ for FGF23 in rats

Iddo Z. Ben‐Dov, Hillel Galitzer, Vardit Lavi-Moshayoff et al. · Journal of Clinical Investigation · 2007 · 950 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson et al. · New England Journal of Medicine · 2003 · 920 citations · Full text

Medicine, Endocrinology, Genetics +15

Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia

Y. Yamazaki, Ryo Okazaki, Minako Shibata et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 675 citations

Medicine, Endocrinology, Pathobiology +14

Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity

Andrew L. Folpe, Julie C. Fanburg–Smith, Steven D. Billings et al. · The American Journal of Surgical Pathology · 2004 · 647 citations

Medicine, Nephrology, Pathology +14